SHANGHAI, China, March 20 /Xinhua-PRNewswire/ -- WuXi PharmaTech today announced the signing of an agreement with CambridgeSoft to significantly increase the number of installed ChemOffice systems. ChemOffice is an industry-leading and a powerful suite of software and are used by hundreds of thousands of chemists, biologists and scientists. The integrated application suite provides solutions in virtually all areas of discovery-from synthesis planning, library enumeration, reagent selection, primary and secondary screening, in vivo testing, through to analysis of results and reporting.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
The current agreement will substantially expand the current user base within the company and make all features of ChemOffice available to WuXi PharmaTech chemists. The complete software suite will not only facilitate the information sharing between chemists at WuXi PharmaTech and its client side, but also pave the way for future addition of chemical and biological informatics system.
''We are very happy to have WuXi PharmaTech as our valued customer in China. WuXi PharmaTech and CambridgeSoft have many common customers in various industry sectors. Licensing additional installed ChemOffice seats from CambridgeSoft shows WuXi PharmaTech's stalwart standing on IP protection and high standards in quality and integrity,'' Akihito Usa -- VP of Pacific Operations of CambridgeSoft Corporation stated.
Dr. Ge Li, Chairman and CEO of WuXi PharmaTech commented, ''The usefulness and versatility of ChemOffice are indisputable from a chemist's point of view. The license agreement with CambridgeSoft transcends the fact that we are their largest customer in China. It exemplifies our commitment to delivering quality services through using quality products. China's cost advantage does not come from using bootlegged software and cutting corners in IP protection.''
At the same time, CambridgeSoft is launching a major marketing campaign in China through its reseller in China -- Beijing Shiji Tianyan Technology Ltd. Co, who facilitated this transaction, with the intention to address the software infringement issue in China, and to urge Chinese customers to purchase the legal licenses. More information can be found at http://www.cambridgesoft.com.cn .
About Wuxi PharmaTech
Founded in 2001, the Shanghai-based WuXi PharmaTech Co., Ltd., is the leader in the pharmaceutical R&D services industry in China. WuXi PharmaTech assists global pharmaceutical and biopharmaceutical companies in shortening the cycle and lowering the cost of drug research and development, and helps clients fully leverage the lower cost R&D capacity in China.
As an integrated drug R&D outsourcing service company, WuXi PharmaTech provides discovery and development services to our partners from lead identification to pre-clinical through our state-of-the-art facilities. The company has a broad service spectrum ranging from lead generation and optimization, in vivo and in vitro ADMET profiling, bioanalytical services, to chemistry process development and large scale manufacturing. There are over 750 scientific staff members and its management team consists of veterans from U.S., India and Japan pharmaceutical industry. WuXi PharmaTech has a 360,000 sq. ft. state-of-the-art research center in WaiGaoQiao Free Trade Zone and a 250,000 sq. ft. and ISO 9001:2000 certified GMP plant in Jinshan Chemical Industry Development Zone, Shanghai. The company's customers include 19 of the top 20 pharmaceutical companies and 8 of the top 10 biopharmaceutical companies in the world.
For more information, please contact: David Yin Public Relations WuXi PharmaTech Tel: +86-21-5046-4003 Email: yin_xiaojun@pharmatechs.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, +1-888-776-6555 or +1-212-782-2840WuXi PharmaTech Co., Ltd.CONTACT: David Yin, Public Relations of WuXi PharmaTech, +86-21-5046-4003,or yin_xiaojun@pharmatechs.com
Web site: http://www.cambridgesoft.com.cn/
